Sarepta Therapeutics Inc (NASDAQ:SRPT) shares, rose in value on Wednesday, March 26, with the stock price down by -0.99% to the previous day’s close as strong demand from buyers drove the stock to $72.88.
Actively observing the price movement in the last trading, the stock closed the session at $73.61, falling within a range of $70.91 and $74.4. The value of beta (5-year monthly) was 0.788 whereas the PE ratio was 30.58 over 12-month period. Referring to stock’s 52-week performance, its high was $173.25, and the low was $72.17. On the whole, SRPT has fluctuated by -31.86% over the past month.
With the market capitalization of Sarepta Therapeutics Inc currently standing at about $7.07 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-25.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 3.14B, with a low estimate of 640.3M and a high estimate of 736.6M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 693.34M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that SRPT’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0.33, with the price of SRPT currently trading nearly -21.26% and -30.43% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 28.83, while the 7-day volatility ratio is showing 5.36% which for the 30-day chart, stands at 5.10%. Furthermore, Sarepta Therapeutics Inc (SRPT)’s beta value is 0.83, and its average true range (ATR) is 5.33.
A comparison of Sarepta Therapeutics Inc (SRPT) with its peers suggests the former has fared considerably weaker in the market. SRPT showed an intraday change of -0.99% in last session, and over the past year, it shrunk by -42.86%%.
Data on historical trading for Sarepta Therapeutics Inc (NASDAQ:SRPT) indicates that the trading volumes over the past 10 days have averaged 3.11 and over the past 3 months, they’ve averaged 1.26 million. According to company’s latest data on outstanding shares, there are 96.90 million shares outstanding.
Nearly 6.07% of Sarepta Therapeutics Inc’s shares belong to company insiders and institutional investors own 91.28% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 4.85 million shares as on 2025-03-14, resulting in a short ratio of 4.51. According to the data, the short interest in Sarepta Therapeutics Inc (SRPT) stood at 522.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 4.92 million. The stock has fallen by -40.06% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the SRPT stock heading into the next quarter.
